Evidence map›Paper›PMID 30232400›Full record

ArticleJournal of human hypertension2018

Increased expression of miR-33a in monocytes from Mexican hypertensive patients in elevated carotid intima-media thickness.

Yazmín Estela Torres-Paz, Claudia Huesca-Gómez, Fausto Sánchez-Muñoz, Rocío Martínez-Alvarado, Ma Elena Soto, Margarita Torres-Tamayo, Giovanny Fuentevilla-Álvarez, Ricardo Gamboa

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of human hypertension, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Yazmín Estela Torres-PazDepartment of Physiology, Instituto Nacional de Cardiología "Ignacio Chávez", México City, Mexico.ORCID http://orcid.org/0000-0001-9835-703X
Claudia Huesca-GómezDepartment of Physiology, Instituto Nacional de Cardiología "Ignacio Chávez", México City, Mexico.
Fausto Sánchez-MuñozDepartment of Immunology, Instituto Nacional de Cardiología "Ignacio Chávez", México City, Mexico.
Rocío Martínez-AlvaradoDepartment of Endocrinology, Instituto Nacional de Cardiología "Ignacio Chávez", México City, Mexico.
Ma Elena SotoDepartment of Immunology, Instituto Nacional de Cardiología "Ignacio Chávez", México City, Mexico.
Margarita Torres-TamayoDepartment of Endocrinology, Instituto Nacional de Cardiología "Ignacio Chávez", México City, Mexico.
Giovanny Fuentevilla-ÁlvarezDepartment of Physiology, Instituto Nacional de Cardiología "Ignacio Chávez", México City, Mexico.
Ricardo GamboaDepartment of Physiology, Instituto Nacional de Cardiología "Ignacio Chávez", México City, Mexico. rgamboaa_2000@yahoo.com.ORCID http://orcid.org/0000-0001-9102-4240
Instituto Nacional de Cardiología · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

miR-33a has been described as a key regulator in the initiation and progression of atherosclerosis. However, its role in arterial hypertension (HTA) has not been elucidated. Therefore, the aim of this study was to determine the association between the expression of miR-33a (5p and 3p) and the carotid intima-media thickness (cIMT) in samples of monocytes and serum from hypertensive patients. The miR-33a-5p and miR-33a-3p expression in monocytes and serum from Mexican hypertensive patients were examined by RT-PCR. This study involved 84 subjects (42 normotensive subjects and 42 patients with essential hypertension). Our study revealed that miR-33a-5p expression was significantly upregulated in the monocytes of hypertensive patients compared with the control group (p = 0.001), while miR-33a-3p was significantly downregulated (p = 0.013). miR-33a-5p upregulation [OR: 5.53, 95% CI: 2.01-15.20; p = 0.001], as well as miR-33a-3p downregulation [OR: 3.32, 95% CI: 1.45-7.60; p = 0.004] in monocytes, was associated with an increased risk of developing hypertension. In addition, miR-33a-5p upregulation in hypertensive patients was associated with an increased risk of presenting cIMT [OR: 5.99, 95% CI: 1.10-32.85; p = 0.039]. Moreover, we found no significant differences in the expression of both strands of miR-33a in serum of our patients. Our results showed an upregulation of miR-33a-5p and downregulation of miR-33a-3p in monocytes, these data are associated with cIMT, which could be a risk factor for the development of hypertension. In addition, upregulation of miR-33a-5p in monocytes from Mexican hypertensive patients could be involved in the development of atherosclerosis.

Indexed as

Carotid Intima-Media ThicknessAgedAngiotensin IAngiotensin IICase-Control StudiesFemaleHumansHypertensionMaleMicroRNAsMiddle AgedMonocytesPeptide FragmentsSterol Regulatory Element Binding ProteinsAngiotensin Iangiotensin I (1-7)Angiotensin IIMicroRNAsMIRN33a microRNA, humanPeptide FragmentsSterol Regulatory Element Binding Proteins

Identifiers

PMID30232400
OpenAlexW2890067079

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.